Multidrug-Resistant Bacteria in the Community: An Update
- PMID: 33011046
- PMCID: PMC8713071
- DOI: 10.1016/j.idc.2020.08.002
Multidrug-Resistant Bacteria in the Community: An Update
Abstract
Multidrug-resistant bacteria are among the most important current threats to public health. Typically, they are associated with nosocomial infections. However, some have become prevalent causes of community-acquired infections, such as Neisseria gonorrhoeae, Shigella, Salmonella, and Streptococcus pneumoniae. The community spread of multidrug-resistant bacteria is also a crucial development. An important global threat on the horizon is represented by production of carbapenemases by community-acquired hypervirulent Klebsiella pneumoniae. Such strains have already been found in Asia, Europe, and North America. Prevention of further community spread of multidrug-resistant bacteria is of the utmost importance, and will require a multidisciplinary approach involving all stakeholders.
Keywords: Carbapenem resistant Enterobacteriaceae; Gonococcus; K pneumoniae; MRSA.
Copyright © 2020 Elsevier Inc. All rights reserved.
References
-
- Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019. In: Department of Health and Human Services, ed. Atlanta, GA,U.S.: CDC, 2019.
-
- Ena J, Dick RW, Jones RN et al. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. Jama 1993; 269: 598–602. - PubMed
-
- Friedman ND, Kaye KS, Stout JE et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Annals of internal medicine 2002; 137: 791–7. - PubMed
-
- Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. The Journal of infectious diseases 2001; 184: 1029–34. - PubMed